Introduction
Epstein-Barr virus (EBV) establishes a latent infection in human B lymphocytes, efficiently transforming the cells into lymphoblastoid cell lines (LCLs), and is implicated in the aetiology of infectious mononucleosis, Burkitths lymphoma (BL), Hodgkinhs disease, nasopharyngeal carcinoma (NPC) and lymphoproliferative diseases in immunocompromised individuals . The virus is capable of adopting four programmes of latency (latency 0, I, II and III). In healthy individuals, latent EBV infection appears to be primarily confined to resting memory B cells (Babcock et al., 1998) . The only EBV gene product that is consistently detected in these cells is the latent membrane protein LMP2A, a pattern of gene expression at present termed latency 0 (Miyashita et Author for correspondence : Lars Rymo.
Fax j46 31 828458. e-mail lars.rymo!clinchem.gu.se Thorley-Lawson et al., 1996) . In Burkitths lymphoma biopsies, only Epstein-Barr virus nuclear antigen 1 (EBNA1) is expressed (latency I) Thorley-Lawson et al., 1996) . In Hodgkinhs disease, NPC and T cell lymphomas, EBNA1 and variable combinations of the three members of the latent membrane protein family (LMP1, LMP2A and LMP2B) are expressed (latency II) Thorley-Lawson et al., 1996) . During acute infectious mononucleosis, in lymphoproliferative syndromes in immunocompromised individuals and in LCLs, all six nuclear antigens (EBNA1-6) are expressed (latency III) . In addition, all three LMPs are expressed (Hudson et al., 1985) . EBV-infected cell lines are either completely non-productive for virus particles or else contain a small subpopulation of cells that have switched spontaneously from a latent stage of infection into the lytic cycle. The mechanism of switching is not fully understood, but one of the first detectable changes in viral gene expression is activation of The sequence co-ordinates are from the DNA sequence of the B95-8 EBV genome (Baer et al., 1984) . The bent arrows indicate the Fp and Qp transcription start sites at positions 62239 and 62429, respectively. (b) Detailed map of previously identified upstream Fp-proximal transcriptional elements and putative transcriptional elements described in this paper. Black boxes indicate AP-1-like sites. Open boxes indicate LR1 and Sp1 sites. (c) Fp fragments present in the different CAT reporter plasmids in relation to the transcriptional elements described in (b). The numbers given in (b) and (c) are positions in relation to the Fp transcription start site (j1).
the EBV immediate-early gene BZLF1, which encodes the lytic switch transactivator ZEBRA, a member of the basic leucine zipper family of DNA-binding proteins . ZEBRA, together with the protein product of the BRLF1 gene, then initiates the lytic cycle cascade (Biggin et al., 1987 ; Countryman & Miller, 1985 ; Hardwick et al., 1988 ; Rooney et al., 1989) . Lytic virus replication is largely restricted in immunologically healthy individuals (Greenspan et al., 1985) . However, infectious virus can be detected in most EBVpositive adults, and it is thought that lytic replication is required for the lifelong persistence of EBV (Ikuta et al., 2000) .
EBNA1-specific initiation of transcription in the restricted pattern of EBV gene expression in latency I B cells and NPC cells was for some time thought to occur at Fp, the promoter in the BamHI F fragment of the EBV genome (Nonkwelo et al., 1995 ; Sample et al., 1991 ; Schaefer et al., 1991) , but more recent data strongly suggest that the dominant EBNA1 gene promoter is Qp, located about 200 bp downstream of Fp in the BamHI Q region (Schaefer et al., 1995b ; Tsai et al., 1995 ; Zetterberg et al., 1999) . Fp is now considered an early lytic promoter (Schaefer et al., 1995a) . A small proportion (1-2 %) of Fp-initiated lytic transcripts is spliced to the EBNA1-encoding K exon (Zetterberg et al., 1999) . However, the majority of Fp-initiated transcripts are not spliced to this exon, at least not at the regular EBNA1 splice acceptor in BamHI K (Schaefer et al., 1995a ; Zetterberg et al., 1999) . The gene product of these transcripts has not been identified.
The regulation of Fp has been the subject of several investigations during the period when Fp was considered a latent EBNA1-specific promoter. Fp was reported to be repressed by binding of EBNA1 to sequences in BamHI Q and to be highly dependent on BamHI Q sequences resembling binding sites for the cellular transcription factors E2F-1 and leader binding protein-1 (Nonkwelo et al., 1995 ; Sung et al., 1994) . However, the measured promoter activity in these experiments most likely arose from Qp. Using a reporter construct that only contained a 146 bp fragment of Fp without sequences from BamHI Q, Bulfone-Paus et al. (1995) identified three positive promoter-proximal cis-acting elements critical for Fp regulation : one Sp1 site and two tandem LR1 sites (Fig.  1) . In earlier work, Lear et al. (1992) showed that Fp was upregulated following the switch from latent into lytic cycle, and raised the possibility that ZEBRA, by an unknown mechanism, could upregulate Fp. In the present investigation we corroborate that Fp is a lytic promoter and show that ZEBRA activates transcription from Fp by binding to a promoter-proximal AP-1-like site.
Methods
Plasmid constructions. All constructs made were verified by dideoxy sequencing (Sanger et al., 1977) using the ABI PRISM Big Dye Terminator Cycle Sequencing kit (PE Applied Biosystems). The Fp transcription initiation site at position 62239 of strain B95-8 EBV DNA (Baer et al., 1984) , Fp, was numbered as j1 (Bulfone-Paus et al., 1995) . The series of chloramphenicol acetyltransferase (CAT) reporter plasmids with different 5h deletions of Fp was constructed as follows. The NheI-BamHI (∆F1), XhoI-BamHI (∆F2), Eco52I-BamHI (∆F3), NarI-BamHI (∆F4) and MluI-BamHI (∆F5) subfragments of the BamHI F fragment of the EBV genome were cloned in the HindIII site of pSVECAT (obtained from M. Yaniv, Institute Pasteur, Paris) replacing the SV40 early control region. The plasmids were named p∆F1CAT, p∆F2CAT, p∆F3CAT, p∆F4CAT and p∆F5CAT, respectively (Fig. 1) . To make an Fp CAT reporter plasmid with a specific promoter-proximal AP-1 mutation, PCR amplification was performed with p∆F5CAT as the template. The 5h primer contained the natural NheI site at position k59 relative to the Fp transcription initiation site and the desired AP-1 mutation (TGACTAA to CAGTCGG, at positions k52 to k46). The 3h primer was specific for a sequence in the CAT gene. The amplified fragment was cleaved with NheI and BamHI and ligated to a SalI-NheI fragment of p∆F5CAT. The resulting fragment was cloned into a SalI-BamHI digested CAT vector, yielding the p∆F5mutCAT plasmid. The expression vector for ZEBRA was kindly provided by G. Miller (Yale University School of Medicine).
Cell lines and induction of virus lytic cycle. The cell lines used in this study and their phenotypic characteristics are listed in Table 1 . All cell lines were propagated in RPMI 1640 (Life Technologies) supplemented with 10 % foetal bovine serum (Life Technologies), penicillin and streptomycin. Induction of the virus lytic cycle in Rael and Mutu gr I was performed by the addition of 5-azacytidine (Sigma) to a concentration of 5 µM (Masucci et al., 1989) . Induction of the virus lytic cycle in Rael was also performed by transfection of 5i10' cells with 10 µg of ZEBRA expression plasmid by electroporation, as described below. Induction of the virus lytic cycle in Akata was performed by the addition of anti-IgG antibodies (DAKO) to a concentration of 0n2% (Takada & Ono, 1989) . Induction of the lytic cycle was confirmed by direct immunofluorescence using a monoclonal anti-ZEBRA antibody (M7005 ; DAKO). 
* Values are expressed as the percentage of chloramphenicol acetylation, using the results obtained with pSVECAT as 100 %, after subtraction of the CAT activity obtained with empty vector (pCAT). Results are means of two independent experiments. Numbers in parentheses indicate the standard errors of the means. † EBNA is abbreviated as E.
Transient transfections and CAT assay. All cell lines were transfected by electroporation (Potter et al., 1984) with a Gene Pulser System (Bio-Rad). Transfections were performed with 5i10' cells and 10 µg of the reporter plasmids. Cells were harvested 2 days after transfection. To study ZEBRA transactivation of Fp, 5i10' DG75 cells were co-transfected with 10 µg of the p∆F5CAT reporter plasmid and either 10 µg of expression vector for ZEBRA (37 pmol) or 8n7 µg of parent empty vector (37 pmol). Cells were harvested 3 days after transfection. Cell extracts were prepared and analysed for CAT activity as previously described (Ricksten et al., 1988) .
RNA analysis. Cytoplasmic RNA was prepared by a standard procedure (Sambrook et al., 1989) . Transcription initiated at Fp in the endogenous EBV genome was determined by S1 mapping using a singlestranded oligonucleotide corresponding to nucleotides 62221-62253 of the L strand of B95-8 EBV DNA : 5h GATCCCCCTCCTCTCTATCCA-CCGCCGCCCCGG 3h. A non-homologous tail of four nucleotides was added at the 3h end of the oligonucleotide to distinguish incomplete digestion of the probe by transcripts initiated further upstream. $#P-endlabelled probe (150 fmol) was annealed for 12-16 h at 37 mC with 100 µg of cytoplasmic RNA in 40 mM PIPES, pH 6n4, 1 mM EDTA, 0n4 mM NaCl and 50 % formamide in a total volume of 20 µl. The hybridization mixture was treated with 750 U\ml of S1 nuclease for 45 min at 37 mC. Protected fragments were fractionated by electrophoresis in a denaturing 12 % polyacrylamide gel. The expected size of a fragment protected by RNA initiated at the Fp transcription start site 62239 is 15 nucleotides.
Electrophoretic mobility shift assay (EMSA). For preparation of ZEBRA-containing nuclear extracts, 40 aliquots, each consisting of 10( DG75 cells, were transfected with 10 µg of ZEBRA expression plasmid by electroporation as described above. Nuclear extracts were prepared 3 days after transfection, essentially as described by Dignam et al. (1983) , except that antipain (5 µg\ml), leupeptin (5 µg\ml) and aprotinin (2 µg\ml) were added to the buffer in the final homogenization and dialysis steps and PMSF was replaced with Pefabloc (0n5 mM). ZEBRA expression was verified by SDS-PAGE and immunoblotting using a monoclonal anti-ZEBRA antibody (M7005 ; DAKO). Aliquots were frozen in liquid nitrogen and stored at k80 mC. A double-stranded, blunt-ended, synthetic oligonucleotide containing the sequence between positions 62179 and 62202 in the EBV genome, (k60\k37)Fp, was used as the probe in the EMSAs. In competition experiments, the following double-stranded consensus oligonucleotides were used : (i) AP-1 consensus : 5h CGCTTGATGACTCAGCCGGAA 3h ; and (ii) sequence identical to the probe, except that the AP-1-like site was transversely mutated (AP-1 mut) : 5h GGCTAGCCCAGTCGGGGGTGAGGC 3h (mutated sequence underlined). Non-specific competitor was an unrelated DNA sequence. One strand of the oligonucleotide probe was labelled with [γ-$#P]ATP (6000 Ci\mmol, NEN Life Science Products) using polynucleotide kinase (Boehringer Mannheim) and annealed to the complementary strand. The labelled probe was purified by electrophoresis in an 8 % polyacrylamide gel in TBE (0n1 M Tris, 0n1 M boric acid, 2 mM EDTA, pH 8n3). The wet gel was autoradiographed and the DNA fragment was excised, electroeluted by isotachophoresis (O = fverstedt et al., 1984) and precipitated. Binding reactions were carried out in a volume of 30 µl containing 10 mM Tris-HCl, pH 7n5, 50 mM NaCl, 1 mM dithiothreitol, 1 mM EDTA, 5 % glycerol, 1 µg poly(dI-dC), 5 fmol labelled probe (approximately 70 000 c.p.m.) and 5 µg of crude nuclear extracts from ZEBRA-transfected DG75. In competition experiments, 3 pmol of unlabelled oligonucleotides were added into the reaction mixture. After incubation at room temperature for 30 min, the samples were loaded on a 6 % polyacrylamide gel (acrylamide : bisacrylamide 29 : 1) in TGE (25 mM Tris-HCl, 0n19 M glycine, 1 mM EDTA, pH 8n3). After electrophoresis gels were dried and autoradiographed. The supershift experiments were performed as described above for the EMSAs except that 2-10 µl of the respective antibody was added after the incubation at room temperature. A second incubation was carried out at 4 mC for 2 h before the samples were loaded on the gel. Antibodies used for supershift experiments were anti-ZEBRA (M7005 ; DAKO), antiSp1 (sc-59X ; Santa Cruz Biotechnology Inc.) and anti-c-Jun (sc-822X ; Santa Cruz Biotechnology Inc.).
Results

Activity of Fp reporter plasmids in cells of different phenotypes
The activity of reporter plasmids carrying Fp and different parts of its 5h flanking sequences (Fig. 1) was determined in a panel of B lymphoid cell lines of different phenotypes and in one EBV-negative T cell line and one EBV-negative epithelial cell line. The results obtained with the CAT reporter plasmids are summarized in Table 1 . The p∆F3CAT, p∆F4CAT and p∆F5CAT plasmids, which contain intermediate or large fragments of Fp, induced expression of CAT only at very low or background levels in all examined cell lines. However, when sequences upstream of k136 (p∆F1CAT and p∆F2CAT) were deleted, Fp induced significant CAT expression in latency I B cells as well as in the EBV-negative cell lines, indicating the presence of a negative regulatory cis-element in the deleted upstream sequences. Invariably, the activity of the short Fp fragments was high in latency I B cells and EBV-negative cells and below detection level in latency III B cells. The very low activity of p∆F1CAT and p∆F2CAT in latency III cells suggests that they may be regulated by transcription factors expressed in a cell-phenotype-dependent manner. Nevertheless, the main finding was the low or undetectable Fp activity in reporter plasmids carrying intermediate or large Fp fragments (p∆F3CAT, p∆F4CAT and p∆F5CAT), confirming that Fp is inactive in EBV-positive cell lines in latent stages of infection and in EBV-negative cell lines.
Fp activity in endogenous virus genomes
To answer the question of whether Fp activity could be detected in the endogenous virus genome and upregulated on induction of the virus lytic cycle, S1 protection analysis was performed. An end-labelled oligonucleotide containing the Fp transcription initiation site at position 62239 was used as the probe (Fig. 2) . Fp-initiated transcripts were only detected in the B95-8 cell line, which contains a significant proportion of spontaneously lytic subpopulations, and in cell lines in which the virus lytic cycle had been induced (Rael ZEBRA, Rael 5azaC, Mutu gr I 5azaC and Akata Ig), corroborating the identity of Fp as an exclusively lytic promoter.
ZEBRA transactivates Fp by binding to a promoterproximal AP-1-like site
The original observation that Fp was activated on induction of the virus lytic cycle led Lear et al. (1992) Wingender et al., 2000) revealed that the Fp regulatory region in p∆F5CAT contained four AP-1-like sites (Fig. 1) . Since ZEBRA is known to transactivate promoters through binding to AP-1-like sites, we hypothesized that ZEBRA could activate Fp directly by this mechanism. We co-transfected EBVnegative DG75 cells with p∆F5CAT or p∆F5mutCAT, in which the AP-1-like site in the k52\k46 Fp region was mutated, together with a ZEBRA expression plasmid (Fig. 3) . The results showed that Fp was transactivated by ZEBRA and that the transactivation was abolished by the promoterproximal AP-1 mutation in spite of the presence of additional upstream AP-1-like sites in the p∆F5mutCAT plasmid. The binding of ZEBRA to the AP-1-like site at the k52\k46 Fp position was investigated by EMSA and antibody supershift analysis using a probe corresponding to the k60\k37 Fp region and nuclear extracts from ZEBRA-transfected DG75 cells (Fig. 4) . Two bands were evident in the extracts. Both bands could be removed by an excess of unlabelled probe and the AP-1 consensus oligonucleotide, but not by an excess of an unrelated sequence or by an oligonucleotide that was identical to the probe except that the AP-1-like site was transversely mutated. The bands were therefore considered specific, representing protein(s) bound to the AP-1-like site. Antibody supershift analysis showed that anti-ZEBRA antibodies supershifted the slowest-moving band. An antibody against the AP-1 component c-Jun did not interact with the complexes. The identity of the fastest-moving band is uncertain, although the competition experiments suggest that the complex consists of protein(s) bound to the AP-1-like site. The intensity of the band was reduced by approximately 30 % in two independent supershift experiments with antibodies against ZEBRA and Sp1, but no supershifted bands were detected with the anti-Sp1 antibody. However, the major findings in the experiments presented in Figs 3 and 4 are that ZEBRA interacts with the AP-1-like site in the k52\k46 Fp region and that this interaction is essential for the ability of ZEBRA to transactivate Fp.
Discussion
ZEBRA plays a fundamental role in disrupting latency and initiating the EBV lytic cascade. Transcriptional activation of the ZEBRA-encoding BZLF1 gene is the primary underlying mechanism by which activators of lytic virus replication exert their effect. ZEBRA shares homology with the DNA-binding domain of the cellular transcription factor c-fos , which is a component of AP-1 (Hunter & Karin, 1992) , and functions as a transactivator that recognizes consensus AP-1 sites, as well as AP-1-like sequences (ZEBRA responsive elements ; ZRE), in several cellular and viral lytic genes involved in the progression of the lytic cycle (Speck et al., 1997 ; Taylor et al., 1991) . In the present study we tested the hypothesis that ZEBRA activates the lytic F promoter by direct binding to the Fp regulatory region. We have confirmed that Fp displays the characteristics of a lytic promoter and have shown that ZEBRA transactivates Fp by binding to a promoterproximal AP-1-like site.
Previous studies of regulatory elements in Fp should be carefully interpreted, since they were undertaken during a period when Fp was considered an EBNA1-specific promoter in latency I and II cells. More recent data have demonstrated that EBNA1-specific initiation of transcription in restricted latency stages arises from the downstream Q promoter (Schaefer et al., 1995b ; Tsai et al., 1995 ; Zetterberg et al., 1999) . Fp was reported to be regulated by sequences in BamHI Q (Nonkwelo et al., 1995 ; Sung et al., 1994) . However, the measured promoter activity in these studies most likely arose from Qp. Bulfone-Paus et al. (1995) investigated a short Fp fragment (146 bp, resembling our p∆F2CAT construct) that spanned the Fp TATA box without BamHI Q sequences. In concordance with our data, their results indicated a remarkably high activity from this short promoter fragment in EBVpositive and -negative B lymphoid cells. They identified three positive cis-acting elements : one Sp1 site and two tandem LR1 sites (Fig. 1) . The activity of the short Fp fragments in our experiments (p∆F1CAT and p∆F2CAT) was high in latency I B cells and EBV-negative cells and below detection level in latency III B cells, suggesting that the promoter fragments may be regulated by viral or cellular transcription factors expressed in a cell-phenotype-dependent manner. Since there are no such differences between latency I and III B cells with regard to Sp1 and LR1, we suggest that viral proteins or other cellular factors may contribute to the differential regulation. For example, latency I cells may contain additional activating factors not identified in this study, or express higher levels of activating factors, whereas latency III cells may contain a repressor(s). The significance of the differential regulation is, however, unclear since the full-length Fp, which presumably is biologically more relevant, behaves in the same manner irrespective of the original latency type, i.e. is repressed in latent cells and upregulated on induction of the virus lytic cycle. Interestingly, there was a significant activity of the short Fp fragments in the epithelial HeLa cell line, which should not contain the B cellspecific transcription factor LR1 (Bulfone-Paus et al., 1995) . Since Sp1 usually functions together with other transcription factors (Ryu et al., 1999) , it will most likely collaborate with other factors in this cell type (Bulfone-Paus et al., 1995) . The promoter-proximal AP-1-like site in the k52\k46 Fp region overlaps one of the LR1 sites (Fig. 1) . However, Bulfone-Paus et al. (1995) ruled out a functional role for AP-1 by binding experiments and by comparing reporter gene expression in cells cultured with and without phorbol 12-myristate 13-acetate. Taken together, it seems that Sp1 and LR1, presumably together with additional factors, activate the short Fp fragments in latency I cells and EBV-negative cells and that this activity is downregulated by a repressor element(s) upstream of k136. It should be noted that two other research groups have employed p∆F2CAT-like reporter plasmids for studying Fp activity and measured a low promoter activity (Schaefer et al., 1995a ; Sung et al., 1994) . In both studies the Fp transcription start site was assigned to nucleotide 62229 in the EBVgenome, 10 bp upstream of the transcription start site defined by Bulfone-Paus et al. (1995) . In our study we detected multiple initiations between positions 62232 and 62239. The consequence of this is that the p∆F2CAT-like construct used by Sung et al. (1994) did not include the major Fp transcription start sites, explaining the low promoter activity in their experiments. The construct used by Schaefer et al. (1995a) was identical to p∆F2CAT, except that it contained the luciferase reporter gene instead of CAT. Thus, there is no obvious explanation for our differing results regarding this specific question. Nevertheless, the main finding of the transient transfection experiments performed in our study was that reporter plasmids carrying larger fragments of Fp (p∆F3CAT, p∆F4CAT and p∆F5CAT) were inactive in all examined cell lines, corroborating that Fp is silent in cells that are not induced to undergo the virus lytic cycle.
Since Fp was silent in strictly latent cells, both in endogenous genomes and in reporter plasmids carrying large fragments of the Fp regulatory region, we asked if Fp activity could be upregulated by induction of the virus lytic cycle. We have shown that endogenous Fp activity was induced by treatment of EBV-infected cells with known activators of lytic virus replication, confirming previous investigations (Lear et al., 1992 ; Schaefer et al., 1995a ; Zetterberg et al., 1999) . Moreover, the silent p∆F5CAT was activated in DG75 cells in the absence of other virus proteins when co-transfected with a ZEBRA expression plasmid. The induction depended on the promoter-proximal AP-1-like site, since p∆F5mutCAT was only expressed at background levels in spite of the presence of ZEBRA. Notably, the AP-1 mutation introduced in the p∆F5mutCAT plasmid changed three bp in the promoterproximal LR1 site (11 bp). However, the substitutions did not significantly reduce the basal activity of Fp in DG75 cells when introduced in p∆F2CAT (data not shown). This finding also supports the conclusion drawn by Bulfone-Paus et al. (1995) that AP-1 is not involved in the regulation of Fp. Moreover, the substitutions did not alter the nucleotides essential for LR1 binding (Dempsey et al., 1998) . EMSA and supershift experiments identified ZEBRA as a component of one of the protein-DNA complexes detected with an oligonucleotide that spanned the k60\k37 Fp region and nuclear extracts from ZEBRA-transfected DG75 cells. We identified one additional band representing protein binding to the AP-1-like site. The intensity of the band was reproducibly slightly reduced by incubation with antibodies against ZEBRA and Sp1. There is no Sp1 binding site in the k60\k37 Fp region. We could not detect the band with nuclear extracts from untransfected DG75 (data not shown). Either the reduced intensity is an unspecific phenomenon, or it might be a result of an interaction between ZEBRA and Sp1. Such an interaction has not yet been described in the literature. In conclusion, we have identified one additional ZEBRA-responsive element in the EBV genome. There are three more AP-1-like sites in the upstream regulatory region of Fp. Conceivably, these are also involved in ZEBRA-induced transactivation of Fp and initiation of the EBV lytic cascade.
A major question remains : what is the 3h end exon of the Fp-initiated transcripts? In a previous investigation of relative levels of EBNA1 gene transcripts in latent and lytic stages of infection, we demonstrated that only 1-2 % of Fp-initiated transcripts in cells induced to virus lytic cycle splice from the U exon to the EBNA1-encoding K exon (FpQ\U\K splicing pattern) (Zetterberg et al., 1999) . The large majority of the Fpinitiated transcripts displayed an FpQ (52-75 % of Fp-initiated transcripts) or FpQ\U (24-47 %) splicing pattern. Furthermore, we identified a BamHI K-containing lytic cycle-specific transcript, which extends upstream of the BamHI f\K cleavage site. It is possible that there is a relationship between the Fp-initiated transcripts with presently unidentified 3h end exon(s) and the lytic cycle-specific BamHI K-containing mRNA, which may give rise to EBNA1. In a study of the transregulatory effects of ZEBRA on different classes of EBV promoters, Kenney et al. (1989) showed that ZEBRA downregulates Cp and Wp. In spite of the downregulation of latent promoters, EBNA1 is not repressed on induction of the virus lytic cycle (Rowe et al., 1992 ; Weigel et al., 1985) . These data suggest that EBNA1 gene transcription in the lytic cycle may be driven by a lytic cycle-specific transcription unit, possibly initiated at Fp, which could compensate for the repression of the latent EBNA1 gene promoters. EBNA1 is known to bind to oriP sequences and enhance nuclear import of oriP-containing plasmids in transient transfection experiments, most probably through its strong nuclear localization signal (La$ ngle-Rouault et al., 1998) . It is tempting to speculate that EBNA1 may serve an important function in the virus lytic cycle through binding to oriP in the genomes of newly packaged virions and facilitate the nuclear import of virus genomes on infection of resting B cells.
